Ismigen podyaz tab. 7 mg 10 pcs

Description

Composition
Active substance:
Lysates of bacteria [Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Klebsiella pneumoniae, Klebsiella ozaenae, Haemophilus influenzae b, Neisseria catarrhalis]
Excipients:
Glycine – 43mg, 150.0 mg microcrystalline cellulose, calcium hydrogen phosphate dihydrate 35.0 mg, colloidal silicon dioxide 10.0 mg Magnesium stearate 3.0 mg Ammonium glycyrrhizinate 1.2 mg, 0.8 mg mint flavor.
Description:
Tablets Valium with Valium, light cream colored with brown patches and weak mint odor.
Product form:
7 mg sublingual tablets. 10 tablets in blisters of PVC film and aluminum foil. 1 blisters together with instructions for use in a stack of cardboard.
Contraindications
Hypersensitivity to the active and / or auxiliary components of the drug, pregnancy, lactation, children under 3 years.
Dosage
7 mg
Indications
Acute and subacute infections of the upper and lower respiratory tract: bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis media, including complications from influenza (treatment as part of combination therapy).
Recurrent infections of the upper and lower respiratory tract, chronic bronchitis (relapse prophylaxis).
Interaction with other drugs
Ismigen may be applied simultaneously with other drugs intended for the treatment of acute and chronic respiratory diseases. Properties Ismigena interaction with other drugs hitherto not been described.
If you apply the above or any other medicines (including OTC), before use of the drug Ismigen® consult your doctor.
Overdose
Information about cases no overdose.
pharmachologic effect
Pharmacological group:
Immunostimulatory agent.
Pharmacological properties:
Combined immunostimulatory preparation of bacterial origin for sublingual (sublingual) administration. It represents a multivalent antigen complex comprising bacterial lysates – the most frequent pathogens of respiratory infections. Lysates are part of Ismigena obtained by mechanical action. Ismigen as other bacterial immunostimulants second generation renders the nonspecific and specific immunostimulatory effect vaccinated.
Ismigen sublingual tablet has an effect on various links of immunity. It stimulates both local cellular and humoral immune response and a systemic immune response. Activates phagocytosis, increases the amount of lysozyme in saliva increases the amount of immunocompetent cells.
It increases the functional and metabolic activity of macrophages (including alveolar) and polymorphonuclear leukocytes. Activates peroxidation and expression of adhesion molecules in monocyte-macrophage cells and granulocytes LEA-1, MAC-1, P-150, ICAT-1, which has a joint with the T-lymphocytes and antigen presenting cells and contributes to the destruction of infectious agents. Stimulates the secretion of macrophage-monocytic cells, prostaglandin E2, activates natural killer cells; stimulates release of inflammatory cytokines – interleukine (IL) -1, IL-2, IL-6, IL-8, gamma-interferon, tumor necrosis factor alpha; inhibits the synthesis of IL-4, IL-12; increases the concentration of secretory immunoglobulin (Ig) A in the saliva, serum IgA, IgG, IgM; reduces the concentration of serum IgE.
As a result, the frequency of treatment Ismigenom reduced the severity and duration of acute respiratory tract infections; there is relief and the leveling of symptoms such as fever, cough, shortness of breath, decreased need for antibacterial and anti-inflammatory therapy; patients with chronic diseases of the respiratory tract drug also prevents exacerbation.
Pregnancy and breast-feeding
Contraindicated.
Conditions of supply of pharmacies
Without recipe.
side effects
The frequency of side effects is classified according to the recommendations of the World Health Organization: very often – more than 10%; often – more than 1 and less than 10%; infrequently – more than 0.1 and less than 1%; rarely – over 0.01 and less than 0.1%; very rarely – less than 0.01%.
For the skin: very rarely – urticaria, impetiginozny dermatitis, folliculitis.
Other: very rarely – an inflammation of the salivary gland, acute laryngitis, rhinitis.
If you have marked side effects listed in the instructions, or they are compounded, or if you notice any other side effects not mentioned in the instructions, tell your doctor.
special instructions
Children aged from 3 to 6 years during reception of each dose until complete dissolution of the tablet in the mouth, should be under adult supervision.
Effects on ability to drive vehicles and operate machinery
It does not affect the ability to drive vehicles, machinery and other classes of potentially hazardous activities that require high concentration and psychomotor speed reactions.
Storage conditions
Store at a temperature not higher than 25 ° C.
Keep out of the reach of children.
Dosing and Administration
Under the tongue; take on an empty stomach. The tablet should be kept under the tongue until complete dissolution. Sublingual tablets should not dissolve, chew or swallow.
Acute and subacute infections of the upper and lower respiratory tract
1 tablet per day until the disappearance of symptoms (no less than 10 days).
Recurrent infections of the upper and lower respiratory tract, prevention of exacerbations of chronic respiratory diseases
1 tablet a day for 10 days. Preventive course comprises three cycles of 10 days with 20-day intervals between them.
Preventive course of conduct should be no more than 1-2 times per year.
When skipping receiving the next dose should not double its next reception.
If after treatment there is no improvement or symptoms are aggravated, or there are new symptoms, you should consult with your doctor. Use according to the drug only indications that the application and in those doses which are specified in the instruction.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist